<DOC>
	<DOCNO>NCT01519518</DOCNO>
	<brief_summary>The purpose study compare unfractionated heparin ( UFH ) bivalirudin performance subsequent outcomes Primary percutaneous coronary intervention . This pragmatic trial . Interventional procedure perform reflect current evolving standard , include predominant radial access . All patient treat routine oral anti-platelet therapy pre-procedure . GP IIb/IIIa inhibitor reserve 'bail ' treatment .</brief_summary>
	<brief_title>How Effective Are Antithrombotic Therapies Primary Percutaneous Coronary Intervention</brief_title>
	<detailed_description>HEAT-PPCI single-centre prospective , dual-arm , open-label , randomise control trial compare two antithrombotic agent patient undergo PPCI . All patient present PPCI service Liverpool Heart Chest Hospital assess trial eligibility . The patient allocate randomisation equal proportion two treatment group receive UFH ( 70 units/kg prior procedure ) bivalirudin ( bolus 0.75 mg/kg prior start intervention , follow infusion 1.75 mg/kg per hour duration procedure ) . Pre-Specified Subgroup Analyses - Subgroup analyse look impact access site compare radial versus femoral route - Assessment outcomes diabetic patient receive oral hypoglycaemic insulin therapy versus patient - Comparing outcome patient &lt; ≥ 75 year age - Type p2y12 receptor inhibit antiplatelet agent ( Examples : clopidogrel , prasugrel , ticagrelor ) - Patients impaired LV function versus normal LV function - Patients manage actual attempted primary PCI versus immediate PCI procedure attempt PLATELET FUNCTION SUBSTUDY A substudy perform assess index coagulation platelet function study compare impact heparin bivalirudin therapy coagulation status end PPCI procedure . This study perform patient treat hour 0800 1600 , Monday Friday . A single blood sample take time general blood sample routine clinical screening analyse .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>All patient present suspected myocardial infarction event PPCI propose index reperfusion strategy include trial ≤ 18 year age Known intolerance , hypersensitivity contraindication trial medication Active bleeding presentation Artificial ventilation , reduce conscious level factor preclude administration oral antiplatelet therapy Previous enrolment trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>ST elevation myocardial infarction</keyword>
	<keyword>Primary percutaneous coronary intervention</keyword>
	<keyword>Unfractionated heparin</keyword>
	<keyword>Bivalirudin</keyword>
	<keyword>primary angioplasty</keyword>
</DOC>